Intractable insomnia after cessation of treatment with thalidomide [6]

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1567-1568

  Fox, M R ^a   Harris, A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; THALIDOMIDE;

AGED; CASE REPORT; CLINICAL EXAMINATION; CROHN DISEASE; DRUG WITHDRAWAL; HUMAN; INSOMNIA; LETTER; MALE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0035053837     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.24495     Document Type: Article

References (6)

1. Thalidomide therapy for patients with refractory Crohn's disease: On open-label trial
2. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
3. Effects of thalidomide and pentobarbital on neuronal activity in the preoptic area during sleep and wakefulness in the cat
4. Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study
5. Thalidomide therapy for Crohn's disease
6. Thalidomide in Crohn's disease